Dexcom is recalling 19 models of its continuous glucose monitoring receivers due to a speaker malfunction that could prevent alerts for dangerous blood sugar levels.
The affected devices are models Dexcom G6, G7, ONE and ONE+ receivers, according to a July 17 news release from the FDA. The recall has been classified as Class I by the agency due to the risk of injury or death.
The receivers are used to alert users when their blood sugar is dangerously high or low and if the speaker fails, individuals could miss critical warnings, the release said.
The company began notifying customers June 9, urging them to check their receiver’s serial number and request a free replacement if affected. Fifty-six injuries have been reported.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.